Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedMar 08, 2026
DataAggregated Company Financials
Companies9
- 7D0.04%
- 3M1.4%
- 1Y15.1%
- YTDn/a
The Biotech industry has been flat over the last week, but Panacea Biotec has lost 3.2%. The past year has been better, since the industry has gained 15% in that time. As for the next few years, earnings are expected to grow by 58% per annum.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Mar 2026 | ₹669.8b | ₹180.6b | ₹6.7b | 58.1x | 100.4x | 3.7x |
| Tue, 03 Feb 2026 | ₹639.7b | ₹177.1b | ₹5.5b | 51.6x | 116.5x | 3.6x |
| Thu, 01 Jan 2026 | ₹567.8b | ₹177.0b | ₹5.5b | 90.1x | 102.9x | 3.2x |
| Sat, 29 Nov 2025 | ₹574.6b | ₹177.0b | ₹5.5b | 94.9x | 104.1x | 3.2x |
| Mon, 27 Oct 2025 | ₹528.3b | ₹169.8b | ₹4.7b | 57.9x | 113.2x | 3.1x |
| Wed, 24 Sep 2025 | ₹528.3b | ₹169.4b | ₹4.6b | 61.7x | 114.1x | 3.1x |
| Fri, 22 Aug 2025 | ₹525.7b | ₹169.4b | ₹4.6b | 64.7x | 113.5x | 3.1x |
| Sun, 20 Jul 2025 | ₹581.3b | ₹163.7b | ₹10.6b | 56.2x | 54.7x | 3.6x |
| Tue, 17 Jun 2025 | ₹477.5b | ₹163.8b | ₹10.6b | 49.7x | 44.9x | 2.9x |
| Thu, 15 May 2025 | ₹461.2b | ₹175.9b | ₹10.6b | 55.9x | 43.5x | 2.6x |
| Sat, 12 Apr 2025 | ₹427.3b | ₹158.8b | ₹8.5b | 47.1x | 50.1x | 2.7x |
| Mon, 10 Mar 2025 | ₹440.7b | ₹158.9b | ₹8.4b | 49.7x | 52.8x | 2.8x |
| Wed, 05 Feb 2025 | ₹490.9b | ₹158.3b | ₹8.2b | 55.2x | 59.5x | 3.1x |
| Fri, 03 Jan 2025 | ₹501.7b | ₹159.6b | ₹14.5b | 64.7x | 34.5x | 3.1x |
| Sun, 01 Dec 2024 | ₹495.4b | ₹159.6b | ₹14.5b | 39.1x | 34.1x | 3.1x |
| Tue, 29 Oct 2024 | ₹434.3b | ₹157.7b | ₹15.7b | 45.3x | 27.7x | 2.8x |
| Thu, 26 Sep 2024 | ₹494.4b | ₹157.7b | ₹15.7b | 33.1x | 31.5x | 3.1x |
| Sat, 24 Aug 2024 | ₹463.2b | ₹157.7b | ₹15.7b | 30.1x | 29.5x | 2.9x |
| Mon, 22 Jul 2024 | ₹439.8b | ₹157.4b | ₹10.4b | 47.7x | 42.4x | 2.8x |
| Wed, 19 Jun 2024 | ₹425.1b | ₹157.4b | ₹10.4b | 44x | 41x | 2.7x |
| Fri, 17 May 2024 | ₹395.8b | ₹155.5b | ₹12.0b | 46.1x | 33x | 2.5x |
| Sun, 14 Apr 2024 | ₹357.1b | ₹155.4b | ₹12.0b | 36.9x | 29.7x | 2.3x |
| Tue, 12 Mar 2024 | ₹361.3b | ₹155.4b | ₹12.0b | 34.8x | 30.1x | 2.3x |
| Thu, 08 Feb 2024 | ₹377.4b | ₹144.9b | ₹5.2b | 67.5x | 72.5x | 2.6x |
| Sat, 06 Jan 2024 | ₹381.3b | ₹145.0b | ₹5.3b | 60.7x | 72.6x | 2.6x |
| Mon, 04 Dec 2023 | ₹317.3b | ₹145.0b | ₹5.3b | 53.7x | 60.4x | 2.2x |
| Wed, 01 Nov 2023 | ₹292.7b | ₹133.7b | ₹4.8b | 34.7x | 61.6x | 2.2x |
| Fri, 29 Sep 2023 | ₹348.0b | ₹133.8b | ₹4.8b | 29.3x | 72.8x | 2.6x |
| Sun, 27 Aug 2023 | ₹435.7b | ₹142.3b | ₹7.2b | 35.3x | 60.7x | 3.1x |
| Tue, 25 Jul 2023 | ₹326.4b | ₹120.4b | ₹4.5b | 42.8x | 72.4x | 2.7x |
| Thu, 22 Jun 2023 | ₹320.4b | ₹120.4b | ₹4.5b | 41.4x | 71.1x | 2.7x |
| Sat, 20 May 2023 | ₹319.0b | ₹106.8b | ₹16.2b | 27.5x | 19.7x | 3x |
| Mon, 17 Apr 2023 | ₹298.7b | ₹106.6b | ₹16.4b | 15x | 18.3x | 2.8x |
| Wed, 15 Mar 2023 | ₹289.1b | ₹106.5b | ₹16.3b | 30.1x | 17.7x | 2.7x |
Price to Earnings Ratio
17.7x
Current Industry PE
- Investors are optimistic on the Indian Biotechnology industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 100x which is higher than its 3-year average PE of 58.3x.
- The 3-year average PS ratio of 2.9x is lower than the industry's current PS ratio of 3.7x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have declined 26% per year over the last three years.
- Meanwhile revenues for these companies have grown 19% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Indian Biotech compare with similar industries?
| IN Market | -3.02% | |
| Healthcare | -0.78% | |
| Biotech | 0.041% | |
| Biotech | 0.041% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹390.70 | 0.2% +₹1.5b | 17.1% | PE104.7x | |
| 514336 Genesis IBRC India | ₹87.12 | 15.5% +₹151.7m | 375.0% | PB13.6x | |
| 526139 Transgene Biotek | ₹2.84 | 6.4% +₹12.9m | -28.6% | PS92.3x | |
| 532041 Hindustan Bio Sciences | ₹8.38 | 10.1% +₹7.9m | 5.0% | PE58.1x |